Credit Suisse’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $141M | Sell |
2,058,101
-62,865
| -3% | -$4.04M | 0.13% | 142 |
|
|
2023
Q4 | $123M | Buy |
2,120,966
+129,116
| +6% | +$6.89M | 0.12% | 162 |
|
|
2023
Q3 | $105M | Buy |
1,991,850
+2,213
| +0.1% | +$116K | 0.11% | 184 |
|
|
2023
Q2 | $108M | Sell |
1,989,637
-69,854
| -3% | -$3.65M | 0.11% | 186 |
|
|
2023
Q1 | $103M | Sell |
2,059,491
-18,457
| -0.9% | -$870K | 0.1% | 195 |
|
|
2022
Q4 | $96.1M | Sell |
2,077,948
-11,841
| -0.6% | -$513K | 0.1% | 206 |
|
|
2022
Q3 | $80.9M | Sell |
2,089,789
-54,317
| -3% | -$2.18M | 0.09% | 231 |
|
|
2022
Q2 | $79.9M | Sell |
2,144,106
-18,250
| -0.8% | -$743K | 0.08% | 248 |
|
|
2022
Q1 | $95.8M | Buy |
2,162,356
+60,757
| +3% | +$2.63M | 0.08% | 265 |
|
|
2021
Q4 | $89.3M | Buy |
2,101,599
+159,323
| +8% | +$6.69M | 0.05% | 407 |
|
|
2021
Q3 | $84.3M | Buy |
1,942,276
+88,002
| +5% | +$3.89M | 0.05% | 427 |
|
|
2021
Q2 | $80.2M | Sell |
1,854,274
-459,523
| -20% | -$19.3M | 0.04% | 466 |
|
|
2021
Q1 | $89.4M | Sell |
2,313,797
-158,817
| -6% | -$6.01M | 0.05% | 446 |
|
|
2020
Q4 | $88.9M | Buy |
2,472,614
+334,879
| +16% | +$12.1M | 0.04% | 463 |
|
|
2020
Q3 | $81.7M | Sell |
2,137,735
-191,269
| -8% | -$7.37M | 0.05% | 414 |
|
|
2020
Q2 | $81.8M | Buy |
2,329,004
+19,217
| +0.8% | +$692K | 0.06% | 344 |
|
|
2020
Q1 | $75.4M | Sell |
2,309,787
-93,760
| -4% | -$3.66M | 0.07% | 292 |
|
|
2019
Q4 | $109M | Buy |
2,403,547
+405,175
| +20% | +$17M | 0.08% | 251 |
|
|
2019
Q3 | $81.3M | Buy |
1,998,372
+34,346
| +2% | +$1.46M | 0.07% | 288 |
|
|
2019
Q2 | $84.4M | Buy |
1,964,026
+385,820
| +24% | +$14.8M | 0.07% | 263 |
|
|
2019
Q1 | $60.6M | Sell |
1,578,206
-180,176
| -10% | -$6.88M | 0.06% | 348 |
|
|
2018
Q4 | $62.1M | Sell |
1,758,382
-60,298
| -3% | -$2.19M | 0.06% | 308 |
|
|
2018
Q3 | $70M | Buy |
1,818,680
+72,865
| +4% | +$2.54M | 0.06% | 312 |
|
|
2018
Q2 | $57.1M | Sell |
1,745,815
-55,742
| -3% | -$1.68M | 0.06% | 349 |
|
|
2018
Q1 | $49.2M | Sell |
1,801,557
-435,527
| -19% | -$11.8M | 0.05% | 421 |
|
|
2017
Q4 | $55.5M | Buy |
2,237,084
+225,507
| +11% | +$6.22M | 0.05% | 391 |
|
|
2017
Q3 | $58.7M | Buy |
2,011,577
+44,538
| +2% | +$1.23M | 0.06% | 369 |
|
|
2017
Q2 | $58.5M | Sell |
1,967,039
-201,192
| -9% | -$5.34M | 0.06% | 346 |
|
|
2017
Q1 | $53.9M | Buy |
2,168,231
+23,686
| +1% | +$576K | 0.05% | 407 |
|
|
2016
Q4 | $46.4M | Sell |
2,144,545
-95,290
| -4% | -$2.08M | 0.05% | 441 |
|
|
2016
Q3 | $53.3M | Buy |
2,239,835
+278,518
| +14% | +$6.64M | 0.05% | 399 |
|
|
2016
Q2 | $45.8M | Sell |
1,961,317
-593,200
| -23% | -$12.8M | 0.05% | 409 |
|
|
2016
Q1 | $48.1M | Buy |
2,554,517
+929,980
| +57% | +$16.3M | 0.06% | 358 |
|
|
2015
Q4 | $30M | Buy |
1,624,537
+160,593
| +11% | +$2.88M | 0.03% | 587 |
|
|
2015
Q3 | $24M | Sell |
1,463,944
-309,789
| -17% | -$5.3M | 0.03% | 644 |
|
|
2015
Q2 | $31.4M | Buy |
1,773,733
+48,384
| +3% | +$865K | 0.03% | 602 |
|
|
2015
Q1 | $30.6M | Sell |
1,725,349
-613,990
| -26% | -$9.7M | 0.03% | 627 |
|
|
2014
Q4 | $31M | Sell |
2,339,339
-82,059
| -3% | -$1.05M | 0.03% | 671 |
|
|
2014
Q3 | $28.6M | Sell |
2,421,398
-355,135
| -13% | -$4.47M | 0.02% | 755 |
|
|
2014
Q2 | $35.5M | Buy |
2,776,533
+548,185
| +25% | +$7.13M | 0.03% | 649 |
|
|
2014
Q1 | $30.1M | Sell |
2,228,348
-462,330
| -17% | -$6.07M | 0.03% | 638 |
|
|
2013
Q4 | $32.3M | Sell |
2,690,678
-40,135
| -1% | -$474K | 0.03% | 585 |
|
|
2013
Q3 | $32.1M | Sell |
2,730,813
-1,279,347
| -32% | -$13.8M | 0.03% | 510 |
|
|
2013
Q2 | $37.2M | Buy |
+4,010,160
| New | +$34M | 0.04% | 478 |
|
Other funds holding BSX
Credit Suisse's BSX Position: Q1 2024 in Review
Credit Suisse reduced its Boston Scientific (BSX) stake by 3% in Q1 2024, selling an estimated $4.04M and leaving 2,058,101 shares worth $141M. The position accounts for 0.13% of the portfolio, ranked #142.
Credit Suisse first reported a position in BSX in Q2 2013 and has held it in 44 quarters since. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.
- Credit Suisse held 2,058,101 shares of Boston Scientific worth $141M as of Q1 2024.
- Credit Suisse sold 62,865 Boston Scientific shares in Q1 2024, an estimated $4.04M.
- Boston Scientific made up 0.13% of Credit Suisse's portfolio in Q1 2024, its #142 holding.
- Credit Suisse first reported a position in Boston Scientific in Q2 2013 and has held it in 44 quarters since.
- 1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.